Luca F, Goichot B, Brue T
Service de Médecine Interne, Nutrition, Endocrinologie, Hôpital de Hautepierre, CHU Strasbourg, 31 Avenue Molière 67098 Strasbourg cedex, France.
Ann Endocrinol (Paris). 2010 Sep;71 Suppl 1:S13-24. doi: 10.1016/S0003-4266(10)70003-2.
Abnormalities in the circulating levels of thyroid hormones, without evidence of coexisting thyroid or pituitary gland disease can be observed in all general diseases. These nonthyroidal illnesses (NTIS) are the result of complex mechanisms that combine the effect of some drugs, cytokines, nutritional and endocrine factors at all levels of the thyrotropic axis, from the hypothalamus to the cellular transporters and nuclear receptors of thyroid hormones. The patterns of NTIS depend on the underlying disease and its severity. Thirtyfive years after the initial description, the pathophysiological significance of these anomalies remains controversial. One of the dilemma of NTIS is whether the hormone responses represent an adaptive and normal, physiologic response to conserve energy and protect against hypercatabolism in case of aggression, or whether it is a maladaptive response contributing to a worsening of the disease. This debate is not just a theoretical question, because in the first case the process must be respected, in the other case a vigorous treatment to restore circulating thyroid hormone levels is justified. There have been very few clinical studies designed to address whether the substitution with thyroid hormone is advantageous, and there is at current time no permissive evidence for the use of thyroid hormone replacement in patients with NTIS. But the clinical context, the choice of the molecule or of the dose and the way of administration were not necessarily the most relevant. Theoretically, stimulation of thyreotrope axis used a continuous infusion of TRH seems to provide clinical benefit. With the expectation that randomized clinical trials will provide demonstration of NTIS treatment efficiency, the question might remain unanswered for several more years.
在所有常见疾病中均可观察到甲状腺激素循环水平异常,且无并存甲状腺或垂体疾病的证据。这些非甲状腺疾病(NTIS)是由复杂机制导致的,这些机制在促甲状腺轴的各个层面(从下丘脑到甲状腺激素的细胞转运体和核受体)综合了某些药物、细胞因子、营养和内分泌因素的作用。NTIS的模式取决于潜在疾病及其严重程度。在最初描述35年后,这些异常的病理生理意义仍存在争议。NTIS的困境之一在于,激素反应是代表一种适应性的正常生理反应,即在遭受攻击时保存能量并防止高分解代谢,还是一种导致疾病恶化的适应不良反应。这场争论不仅仅是一个理论问题,因为在第一种情况下必须尊重这个过程,而在另一种情况下,积极治疗以恢复循环甲状腺激素水平是合理的。很少有临床研究旨在探讨甲状腺激素替代是否有益,目前也没有允许在NTIS患者中使用甲状腺激素替代的证据。但临床背景、分子或剂量的选择以及给药方式不一定是最相关的。理论上,使用促甲状腺轴的连续输注TRH刺激似乎能带来临床益处。期望随机临床试验能证明NTIS治疗的有效性,这个问题可能还会在未来几年内得不到答案。